Clinical Trials Sponsored by Lantheus Medical Imaging

Total 334 results

Lantheus Medical Imaging

Not yet recruiting

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer (PHANTOM)

Sarcoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Metastatic Sarcoma
Lantheus Medical Imaging

Completed

A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

Coronary Artery Disease | Heart Disease

United States
Lantheus Medical Imaging

Completed

A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure

Pulmonary Heart Disease

United States
Lantheus Medical Imaging

Completed

Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY® (DEF-418)

Cardiovascular Disease

United States
Lantheus Medical Imaging

Completed

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

Healthy

United States
Lantheus Medical Imaging

Completed

Study of [3H] BMS747158 in Healthy Male Subjects (PPA103)

Coronary Artery Disease

United States
Lantheus Medical Imaging

Withdrawn

Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing (LMI1195-201)

Heart Failure

United States
Lantheus Medical Imaging

Completed

Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158

Ischemia

United States
Lantheus Medical Imaging

Withdrawn

A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD)

United States
Lantheus Medical Imaging

Completed

DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

Ventricular Ejection Fraction

United States
Lantheus Medical Imaging

Recruiting

PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer (MIRROR)

Prostate Cancer

United States
Lantheus Medical Imaging

Completed

A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

Cardiovascular Disease

United States
Lantheus Medical Imaging

Completed

A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

Heart Failure

United States
Lantheus Medical Imaging

Completed

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

Kawasaki Disease

United States, Brazil, Canada, Taiwan, Philippines, Thailand, Korea, Republic of
Lantheus Medical Imaging

Completed

Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR

Nephrogenic Systemic Fibrosis

United States
Lantheus Medical Imaging

Withdrawn

Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI

Coronary Artery Disease
Lantheus Medical Imaging

Completed

A Phase II Study of DMP 115 to Assess Focal Liver Lesions

Liver Disease

United Kingdom
Lantheus Medical Imaging

Completed

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Coronary Artery Disease

United States, Canada, Puerto Rico, Finland
Lantheus Medical Imaging

Completed

A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress

Healthy Volunteers

United States
Lantheus Medical Imaging

Completed

A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects

Kawasaki Disease

United States, Taiwan, Canada
Lantheus Medical Imaging

Completed

CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI

Myocardial Infarction

United States, Canada, Brazil
Lantheus Medical Imaging

Completed

A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.

Diabetes

United States, Canada
Lantheus Medical Imaging

Completed

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

Diabetes Mellitus, Type 2 | Coronary Restenosis

Puerto Rico, United States
PPsanalytics
Lantheus Medical Imaging

Not yet recruiting

An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer

Prostate Cancer
Foothills Medical Centre
Lantheus Medical Imaging

Completed

Can Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT) Contrast Agents (CEUS_CT)

Nephrotoxicity of CT Contrast Agents | CT Scans in Those With Renal Compromise | Sensitivity to CT Contrast Agents | US With CEUS as Replacement for Unenhanced CT Scan

Canada
Lantheus Medical Imaging
Syneos Health

Completed

DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY (BENEFIT2)

Cardiac Disease

United States
Duke University
Lantheus Medical Imaging

Completed

Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants

Healthy

United States
Lantheus Medical Imaging
POINT Biopharma

Available

Expanded Access Treatment With [Lu-177]-PNT2002 for Adult Patients With Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Castration-Resistant Prostatic Cancer

United States
Lantheus Medical Imaging
Syneos Health

Completed

DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY (BENEFIT1)

Cardiac Disease

United States
Mayo Clinic
Lantheus Medical Imaging

Completed

Real-Time Myocardial Perfusion Echocardiography in the ICU

Myocardial Perfusion Imaging

United States
University of Pittsburgh
Lantheus Medical Imaging

Completed

Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events

Coronary Artery Disease

United States
M.D. Anderson Cancer Center
Lantheus Medical Imaging

Recruiting

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

Breast Cancer | Hepatocellular Carcinoma | Pancreatic Cancer

United States
University of California, Davis
Lantheus Medical Imaging

Enrolling by invitation

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Breast Cancer | Prostate Cancer | Neuroendocrine Tumors

United States
University Health Network, Toronto
Lantheus Medical Imaging

Completed

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

Renal Cell Carcinoma

Canada
Albert Einstein Healthcare Network
Lantheus Medical Imaging

Completed

Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification

Mitral Annulus Calcification

United States
Dr. Amer Johri
Lantheus Medical Imaging

Completed

Early Detection of Cardiovascular Disease (VIBE)

Myocardial Infarction | Vascular Diseases | Atherosclerosis | Acute Coronary Syndrome | Cardiac Disease | Atheroma

Canada
Weill Medical College of Cornell University
Lantheus Medical Imaging

Completed

Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction

Myocardial Infarction | Thrombus

United States
Dr. Amer Johri
Lantheus Medical Imaging

Recruiting

Carotid Intraplaque Neovascularization Combined With Stress Echo (CIRCE)

Myocardial Infarction | Cardiovascular Diseases | Atherosclerosis | Carotid Artery Diseases | Acute Coronary Syndrome | Ischemic Heart Disease

Canada
UNC Lineberger Comprehensive Cancer Center
Lantheus Medical Imaging

Completed

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau (CEUS-VHL)

Kidney Disease, Chronic | Von-Hippel Lindau

United States
Washington University School of Medicine
Lantheus Medical Imaging

Completed

Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)

Pulmonary Embolism
University of North Carolina, Chapel Hill
Lantheus Medical Imaging

Completed

Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension (CEUS-CKDx)

Chronic Kidney Diseases | Cystic Kidney Disease

United States
The University of Texas Medical Branch, Galveston
Lantheus Medical Imaging

Completed

Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly

Aging

United States
Northwestern University
Bristol-Myers Squibb; Lantheus Medical Imaging; CarThera

Recruiting

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma (SC9/ABX)

Glioblastoma | Glioblastoma Multiforme | Gliosarcoma | GBM | Recurrent Glioblastoma | Glioblastoma, IDH-wildtype

United States
Thomas Jefferson University
Rothman Institute Orthopaedics; Lantheus Medical Imaging

Completed

Diagnosing Compartment Syndrome With SHAPE vs Elastography

Chronic Exertional Compartment Syndrome

United States
Thomas Jefferson University
American Heart Association; Lantheus Medical Imaging

Completed

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Heart Failure | Blood Pressure | Cardiac Catheterization | Echocardiography | Heart Ventricles

United States
VA Greater Los Angeles Healthcare System
Lantheus Medical Imaging

Not yet recruiting

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Prostate Cancer Diagnosis

United States
London North West Healthcare NHS Trust
Lantheus Medical Imaging

Active, not recruiting

Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings (ELVIS)

Contrast Echocardiography Imaging

United Kingdom
E. Peden, MD
The Methodist Hospital Research Institute; Lantheus Medical Imaging

Completed

Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair (AAA CEUS)

Endoleaks

United States
Mayo Clinic
St. Boniface Hospital; Lantheus Medical Imaging; The Asper Foundation

Completed

Early Detection of Broken Hearts in Cancer Patients (ASPER)

Cardiotoxicity

United States, Canada
Mayo Clinic
Astellas Pharma US, Inc.; University of Nebraska; Lantheus Medical Imaging

Completed

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes (GLP-1)

Coronary Artery Disease | Diabetes Mellitus Type 2

United States

Clinical Trials Sponsored by Lantheus Medical Imaging

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations